Furthermore, accumulating evidence explained the involvement of liquiritigenin on PI3K/Akt pathway, suggesting that it possesses anti-tumor properties by inhibiting cell proliferation and migration via PI3K/Akt pathway in human lung adenocarcinoma [35]. The gene discussed is AKT1; the disease is lung adenocarcinoma.